Skip to content

To compare the effect of Shigrupatra Arka and nagaradi rasa Aschyotana in kaphaja abhishyanda(VKC)

Comparative clinical evaluation of aschyotana with Shigrupatra Arka and nagaradi Ras in Kaphaja abhishyanda - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113260
Enrollment
60
Registered
2026-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Sponsors

Patanjali Bhartiya Ayurvigyan Evum Anusandhan Sansthan Haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical symptoms of kaphaja abhishyanda and vernal kerato conjuctivitis Patients between age group of 5 years to 25 years of either gender Patients with symptoms like itching, photophobia,lacrimation,ropy discharge and heaviness of lids

Exclusion criteria

Exclusion criteria: Patients suffering from any other eye diseases like corneal xerosis,corneal ulcer, dacryocystitis,and infective conjuctivitis Patients suffering from other systemic disease and metabolic disorders

Design outcomes

Primary

MeasureTime frame
Subjective parameters: Kandu (Itching in the eye). Guruta(Heaviness in the eye). Muhur muhursrava (Repeated discharge from the eye). Pichhila srava (Slimy discharge from the eye). Burning sensation. Photophobia. Timepoint: 0,15,30 day

Secondary

MeasureTime frame
Objective parameters: Palpebral conjunctiva hypertrophy Palpebral conjunctival congestion Bulbar conjunctival congestion Hornertranta s dots (Limbal area) Absolute eosinophils count Timepoint: 0,15,30 day

Countries

India

Contacts

Public ContactArpit panwar

Patanjali Bhartiya Ayurvigyan Evum Anusandhan Sansthan Haridwar

agrawal.amitkumar308@gmail.com8954890271

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026